4.5 Article

Do mood instability symptoms in epilepsy represent formal bipolar disorder?

期刊

EPILEPSIA
卷 53, 期 2, 页码 e37-e40

出版社

WILEY
DOI: 10.1111/j.1528-1167.2011.03372.x

关键词

Epilepsy; Bipolar; Depression

资金

  1. GlaxoSmithKline
  2. Ortho-McNeil Janssen Scientific Affairs
  3. AstraZeneca
  4. Endo Pharmaceuticals
  5. Allergan
  6. Merck

向作者/读者索取更多资源

We aimed to assess rates of bipolar symptoms versus bipolar disorder in epilepsy, and the effect of bipolar symptoms on quality of life (QOL) in epilepsy. Bipolar, disability, and QOL instruments were administered to 99 tertiary epilepsy center patients. Patients who scored positive on the Mood Disorder Questionnaire (MDQ) also completed depression scales and a structured psychiatric interview. Results indicated MDQ+ patients (10.1%) had worse QOL and more work, social, and family life disruptions. Most MDQ+ patients did not have bipolar disorder. There was close overlap between depressive and bipolar symptomatology. Based on results of this study, bipolar symptom is not synonymous with bipolar disorder. Symptoms picked up by the MDQ may be epilepsy-related depressive symptoms. Bipolar symptoms are associated with more disability, worse QOL, and may have treatment implications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据